1539-3429/asset/BMB_left.gif?v=1&s=b620b4ceb5536034852387ab6f7893ce7746164f)
1539-3429/asset/BMB_right.gif?v=1&s=bec016690584f1fcd9f6d746fb998a8820b1d069)
Feature
HPV vaccine development: A case study of prevention and politics
Article first published online: 3 NOV 2006
DOI: 10.1002/bmb.2006.49403402148
Copyright © 2006 International Union of Biochemistry and Molecular Biology, Inc.
1539-3429/asset/cover.gif?v=1&s=fa4eec691a239b2ca4ee33a2b67e6356cc6d82fb "Biochemistry and Molecular Biology Education")
Additional Information
How to Cite
Grimes, J. L. (2006), HPV vaccine development: A case study of prevention and politics. Biochem. Mol. Biol. Educ., 34: 148–154. doi: 10.1002/bmb.2006.49403402148
Publication History
- Issue published online: 3 NOV 2006
- Article first published online: 3 NOV 2006
- Manuscript Received: 26 DEC 2005
- Abstract
- Article
- References
- Cited By
Keywords:
- HPV;
- human papillomavirus;
- vaccine;
- cervical cancer
Abstract
An analysis of the development of human papillomavirus (HPV) vaccines requires a fundamental comprehension of the underlying science of the technology, as well as an appreciation for the business issues essential to successful commercialization. Students analyzing this topic must consider scientific challenges related to the development of these vaccines, as well as the implications for their commercialization. This case study describes the evolution of our understanding of HPV infection and its causative link to cervical cancer, the establishment of viable HPV vaccine candidates, and various issues related to HPV vaccine implementation. Study questions for use in generating class discussion are provided.